---
figid: PMC5077201__zbc0461654680006
figlink: /pmc/articles/PMC5077201/figure/F6/
number: F6
caption: A possible model of TIPE2 inhibition of activation of TAK1 signaling. When
  TLR, IL-1R, and TNFR are stimulated via binding with their specific ligands, TAK1
  is activated through subsequent downstream molecular events in the TAK1 signaling
  pathway. This study demonstrates that TIPE2 (aa 101–140) interacts with TAK1 via
  binding to the internal kinase domain (aa 200–291) of TAK1. Consequently, formation
  of the TAK1-TAB1-TAB2 complex is inhibited, as are the subsequent phosphorylation
  and ubiquitination of TAK1. Therefore, the negative regulation by TIPE2 of TAK1
  activation may contribute to suppression of TAK1-NF-κB-mediated inflammatory responses.
pmcid: PMC5077201
papertitle: TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative
  Regulator of TAK1 Signal.
reftext: Michitaka Oho, et al. J Biol Chem. 2016 Oct 21;291(43):22650-22660.
pmc_ranked_result_index: '85883'
pathway_score: 0.9380877
filename: zbc0461654680006.jpg
figtitle: Possible model of TIPE2 inhibition of activation of TAK1 signaling
year: '2016'
organisms: Homo sapiens
ndex: 01b8ba38-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5077201__zbc0461654680006.html
  '@type': Dataset
  description: A possible model of TIPE2 inhibition of activation of TAK1 signaling.
    When TLR, IL-1R, and TNFR are stimulated via binding with their specific ligands,
    TAK1 is activated through subsequent downstream molecular events in the TAK1 signaling
    pathway. This study demonstrates that TIPE2 (aa 101–140) interacts with TAK1 via
    binding to the internal kinase domain (aa 200–291) of TAK1. Consequently, formation
    of the TAK1-TAB1-TAB2 complex is inhibited, as are the subsequent phosphorylation
    and ubiquitination of TAK1. Therefore, the negative regulation by TIPE2 of TAK1
    activation may contribute to suppression of TAK1-NF-κB-mediated inflammatory responses.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NR2C2
  - NFKB1
  - TLR6
  - TLR7
  - TAB2
  - TLR8
  - TAB1
  - TRAF6
  - TLR2
  - TLR5
  - TNFRSF1A
  - TRAF2
  - TLR1
  - TLR4
  - TLR3
  - TLR10
  - TLR9
genes:
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TAB1
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
chemicals: []
diseases: []
figid_alias: PMC5077201__F6
redirect_from: /figures/PMC5077201__F6
figtype: Figure
---
